تحميل...
Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the future
Multiple Sclerosis (MS) is an autoimmune inflammatory disease of the central nervous system (CNS) which affects over 2.5 million people worldwide. Although MS has been extensively studied, many challenges still remain in regards to treatment, diagnosis, and prognosis. Typically, prognosis and indivi...
محفوظ في:
| الحاوية / القاعدة: | Expert Rev Clin Immunol |
|---|---|
| المؤلفون الرئيسيون: | , , , , |
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
2014
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4326231/ https://ncbi.nlm.nih.gov/pubmed/25523168 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/1744666X.2015.991315 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|